643 related articles for article (PubMed ID: 25751261)
1. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer.
Viljoen KS; Dakshinamurthy A; Goldberg P; Blackburn JM
PLoS One; 2015; 10(3):e0119462. PubMed ID: 25751261
[TBL] [Abstract][Full Text] [Related]
2. Association of oncogenic bacteria with colorectal cancer in South China.
Zhou Y; He H; Xu H; Li Y; Li Z; Du Y; He J; Zhou Y; Wang H; Nie Y
Oncotarget; 2016 Dec; 7(49):80794-80802. PubMed ID: 27821805
[TBL] [Abstract][Full Text] [Related]
3. High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients.
Khodaverdi N; Zeighami H; Jalilvand A; Haghi F; Hesami N
BMC Cancer; 2021 Dec; 21(1):1353. PubMed ID: 34937552
[TBL] [Abstract][Full Text] [Related]
4. [Expression of enterotoxigenic Bacteroides fragilis and polyketide synthase gene-expressing Escherichia coli in colorectal adenoma patients].
Xie LL; Wu N; Zhu YM; Qiu XY; Chen GD; Zhang LM; Liu YL
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(12):954-9. PubMed ID: 27045721
[TBL] [Abstract][Full Text] [Related]
5. Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development.
Lennard KS; Goosen RW; Blackburn JM
PLoS One; 2016; 11(11):e0166282. PubMed ID: 27846243
[TBL] [Abstract][Full Text] [Related]
6. Enterotoxigenic
Zamani S; Taslimi R; Sarabi A; Jasemi S; Sechi LA; Feizabadi MM
Front Cell Infect Microbiol; 2019; 9():449. PubMed ID: 32010637
[TBL] [Abstract][Full Text] [Related]
7. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.
Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D
Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031
[TBL] [Abstract][Full Text] [Related]
8. Colon Tumors in Enterotoxigenic Bacteroides fragilis (ETBF)-Colonized Mice Do Not Display a Unique Mutational Signature but Instead Possess Host-Dependent Alterations in the APC Gene.
Allen J; Rosendahl Huber A; Pleguezuelos-Manzano C; Puschhof J; Wu S; Wu X; Boot C; Saftien A; O'Hagan HM; Wang H; van Boxtel R; Clevers H; Sears CL
Microbiol Spectr; 2022 Jun; 10(3):e0105522. PubMed ID: 35587635
[TBL] [Abstract][Full Text] [Related]
9. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.
Boleij A; Hechenbleikner EM; Goodwin AC; Badani R; Stein EM; Lazarev MG; Ellis B; Carroll KC; Albesiano E; Wick EC; Platz EA; Pardoll DM; Sears CL
Clin Infect Dis; 2015 Jan; 60(2):208-15. PubMed ID: 25305284
[TBL] [Abstract][Full Text] [Related]
10. The association between fecal enterotoxigenic B. fragilis with colorectal cancer.
Haghi F; Goli E; Mirzaei B; Zeighami H
BMC Cancer; 2019 Sep; 19(1):879. PubMed ID: 31488085
[TBL] [Abstract][Full Text] [Related]
11. [The Relationship of Enterotoxigenic Bacteroides fragilis and Fusobacterium nucleatum Intestinal Colonization with Colorectal Cancer: A Case-Control Study Performed with Colon Biopsies].
Öztürk Bakar Y; Demiryas S; Ceylan Kılınçarslan A; Demirci M; Kepil N; Bakar MT; Taner Z; Tokuç E; Ziyad MA; Taşçı İ; Kocazeybek BS; Bahar Tokman H
Mikrobiyol Bul; 2023 Jul; 57(3):353-364. PubMed ID: 37462300
[TBL] [Abstract][Full Text] [Related]
12. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
[TBL] [Abstract][Full Text] [Related]
13. Screening for enterotoxigenic Bacteroides fragilis in stool samples.
Keenan JI; Aitchison A; Purcell RV; Greenlees R; Pearson JF; Frizelle FA
Anaerobe; 2016 Aug; 40():50-3. PubMed ID: 27166180
[TBL] [Abstract][Full Text] [Related]
14. The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer.
Rezasoltani S; Asadzadeh Aghdaei H; Dabiri H; Akhavan Sepahi A; Modarressi MH; Nazemalhosseini Mojarad E
Microb Pathog; 2018 Nov; 124():244-249. PubMed ID: 30142468
[TBL] [Abstract][Full Text] [Related]
15. Detection of
Périchon B; Lichtl-Häfele J; Bergsten E; Delage V; Trieu-Cuot P; Sansonetti P; Sobhani I; Dramsi S
Front Cell Infect Microbiol; 2022; 12():794391. PubMed ID: 35360109
[TBL] [Abstract][Full Text] [Related]
16. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia.
Purcell RV; Pearson J; Aitchison A; Dixon L; Frizelle FA; Keenan JI
PLoS One; 2017; 12(2):e0171602. PubMed ID: 28151975
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
Rye MS; Garrett KL; Holt RA; Platell CF; McCoy MJ
PLoS One; 2022; 17(1):e0262416. PubMed ID: 34995318
[TBL] [Abstract][Full Text] [Related]
18. Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort.
Butt J; Jenab M; Werner J; Fedirko V; Weiderpass E; Dahm CC; Tjønneland A; Olsen A; Boutron-Ruault MC; Rothwell JA; Severi G; Kaaks R; Turzanski-Fortner R; Aleksandrova K; Schulze M; Palli D; Pala V; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Van Gils CH; Gram IT; Lukic M; Sala N; Sánchez Pérez MJ; Ardanaz E; Chirlaque MD; Palmquist R; Löwenmark T; Travis RC; Heath A; Cross AJ; Freisling H; Zouiouich S; Aglago E; Waterboer T; Hughes DJ
Gut Microbes; 2021; 13(1):1-14. PubMed ID: 33874856
[TBL] [Abstract][Full Text] [Related]
19. [Relationships between the enrichment of ETBF, Fn, Hp in intestinal and colorectal cancer].
Zhang J; Lu XL; Zhao G; Shi HT; Geng Y; Zhong WT; Dong L
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):99-104. PubMed ID: 29502368
[No Abstract] [Full Text] [Related]
20. Intratumoral presence of the genotoxic gut bacteria pks
Joo JE; Chu YL; Georgeson P; Walker R; Mahmood K; Clendenning M; Meyers AL; Como J; Joseland S; Preston SG; Diepenhorst N; Toner J; Ingle DJ; Sherry NL; Metz A; Lynch BM; Milne RL; Southey MC; Hopper JL; Win AK; Macrae FA; Winship IM; Rosty C; Jenkins MA; Buchanan DD
Br J Cancer; 2024 Mar; 130(5):728-740. PubMed ID: 38200234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
